
Pentoclove 40mg Injection
Marketer
Mediclove Biotech Pvt Ltd
Salt Composition
Pantoprazole (40mg)
Overview Pentoclove 40mg Injection
Gastrilow 40mg Injection lowers stomach acid production. It treats acid-related stomach and intestinal disorders, including gastroesophageal reflux disease, peptic ulcers, and Zollinger-Ellison syndrome, relieving symptoms and promoting healing. This intravenous injection, administered by a healthcare provider, is reserved for patients where oral medication is unsuitable. It's also used for stress ulcer prophylaxis in critically ill individuals and pre-anesthesia to mitigate aspiration risks. Gastrilow 40mg belongs to the proton pump inhibitor (PPI) class. Dosage depends on your condition and response; follow your doctor's prescribed treatment duration, even with rapid symptom improvement. Lifestyle modifications like frequent, smaller meals and avoidance of caffeine, spicy, and fatty foods can enhance treatment effectiveness. Common side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). While usually mild, persistent or bothersome side effects require medical attention. Prolonged use (over one year) may elevate bone fracture risk, particularly at higher doses. Discuss bone health strategies, such as calcium and vitamin D supplementation, with your physician. Gastrilow 40mg is contraindicated in individuals with severe hepatic impairment, those on HIV medications, those with a history of PPI allergy, or pre-existing osteoporosis. Pregnant or breastfeeding women should seek medical advice. Alcohol should be avoided due to its acid-stimulating effects. Refrain from operating machinery if dizziness or drowsiness occurs.
Primary Ingredients of Pentoclove 40mg Injection
The provided text is "undefined," therefore no rewriting is possible.
Uses of Pentoclove 40mg Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Pentoclove 40mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Pentoclove 40mg Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Pentoclove 40mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Pentoclove 40mg Injection works:
Acidity Relief Injection, Pentoclove 40mg, functions as a proton pump inhibitor, decreasing gastric acid production to alleviate symptoms of heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Combining Pentoclove 40mg Injection and alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
The use of Pentoclove 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administering a 40mg Pentoclove injection while breastfeeding is likely safe. Available human data indicates minimal infant risk associated with this medication.
DrivingCONSULT YOUR DOCTOR
Pentoclove 40mg Injection's effect on driving ability is undetermined. Refrain from operating a vehicle if you encounter symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Pentoclove 40mg Injection is considered safe for administration. No alteration of the Pentoclove 40mg Injection dosage is necessary.
LiverCAUTION
For individuals with significant hepatic impairment, administering Pentoclove 40mg Injection requires careful consideration. Dosage modification of Pentoclove 40mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Pentoclove 40mg Injection :
Forgetting a dose of Pentoclove 40mg Injection? Contact your physician for guidance.
Facts to Know About Pentoclove 40mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Gastric acid suppressants |
